Kazia Therapeutics Ltd (KZIA) is down Monday morning, with the stock decreasing -4.63% in pre-market trading to 1.03. KZIA's short-term technical score of 31 indicates that the stock has traded less bullishly over the last month than 69% of stocks on the market. In the Biotechnology industry, which ranks 125 out of 146 industries, KZIA ranks higher than 50% of stocks. Kazia Therapeutics Ltd has fallen 15.63% over the past month, closing at $1.25 on June 12. During this period of time, the stock fell as low as $1.07 and as high as $1.33. KZIA has an average analyst recommendation of Buy. The company has an average price target of $2.00.
News Home
Kazia Therapeutics Ltd has a Long-Term Technical rank of 52. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 48% of the market scoring higher. In the Biotechnology industry which is number 119 by this metric, KZIA ranks better than 119% of stocks.
Kazia Therapeutics Ltd (KZIA) has fallen 4.63% Monday In Premarket Trading
Mentioned in this article
KZIA has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on KZIA!